why isn't bpc 157 fda approved BPC-157's Review Raises Questions About Its Origins | American Peptide Society posted on the topic FDA's Overreach on Compounded Peptides
Description
10.1016/j.lfs.2011.01.015 [DOI] [PubMed] [Google Scholar] Ilic S., Drmic D., Zarkovic K., Kolenc D., Brcic L., Radic B., et al

3-Year Shelf Life: Ensures product stability and efficacy for up to 3 years when stored properly

It transfers risk from the development pipeline directly onto patients, without their informed consent, because the information required for consent doesn't exist yet
Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog
